Related Experiment Video
Updated: Apr 5, 2026

Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
Published on: June 26, 2018
Sacral nerve stimulation for faecal incontinence and constipation in adults
Mohamed A Thaha1, Amin A Abukar, Noel N Thin
1Academic Surgical Unit, National Centre for Bowel Research & Surgical Innovation, Centre for Digestive Diseases, Blizard Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University London, 1st Floor, Abernethy Building, 2 Newark Street, The Royal London Hospital, Whitechapel, London, England, UK, E1 2AT.
Sacral nerve stimulation (SNS) shows promise for treating fecal incontinence (FI) by reducing episodes, but its effectiveness for constipation is unclear. Some patients experience adverse events, necessitating further research.
Area of Science:
- Urology and Gastroenterology
- Neurosurgery
- Medical Devices
Background:
- Faecal incontinence (FI) and constipation significantly impair quality of life.
- Traditional surgical interventions carry risks and have variable outcomes.
- Sacral nerve stimulation (SNS) offers a less-invasive surgical option for these conditions.
Purpose of the Study:
- To evaluate the efficacy of sacral nerve stimulation (SNS) using implanted electrodes.
- To assess SNS effects on fecal incontinence (FI) and constipation in adults.
Main Methods:
- Systematic review of randomized and quasi-randomized controlled trials.
- Searched multiple databases including Cochrane, MEDLINE, EMBASE, and ClinicalTrials.gov.
- Independent screening, quality assessment, and data extraction by two authors.
Main Results:
- Limited trials suggest SNS improves continence in some FI patients.
- One trial showed reduced FI episodes compared to optimal medical therapy.
- Evidence for SNS effectiveness in constipation is inconclusive, with some trials showing no improvement and reporting adverse events.
Conclusions:
- Sacral nerve stimulation (SNS) may benefit a subset of patients with fecal incontinence (FI).
- Current evidence does not support SNS for treating constipation.
- Further high-quality randomized trials are required to confirm SNS efficacy and safety for both conditions.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Irritable Bowel Syndrome III: Medical and Nursing Management

